JP2021097671A5 - - Google Patents

Download PDF

Info

Publication number
JP2021097671A5
JP2021097671A5 JP2021015026A JP2021015026A JP2021097671A5 JP 2021097671 A5 JP2021097671 A5 JP 2021097671A5 JP 2021015026 A JP2021015026 A JP 2021015026A JP 2021015026 A JP2021015026 A JP 2021015026A JP 2021097671 A5 JP2021097671 A5 JP 2021097671A5
Authority
JP
Japan
Prior art keywords
nucleic acid
seq
nos
sequences
intergenic region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021015026A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021097671A (ja
Filing date
Publication date
Priority claimed from JP2017093388A external-priority patent/JP6867866B2/ja
Application filed filed Critical
Publication of JP2021097671A publication Critical patent/JP2021097671A/ja
Publication of JP2021097671A5 publication Critical patent/JP2021097671A5/ja
Pending legal-status Critical Current

Links

JP2021015026A 2011-06-01 2021-02-02 細菌のポリシストロン性発現系 Pending JP2021097671A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP11168495.7 2011-06-01
EP11168495 2011-06-01
EP11173588.2 2011-07-12
EP11173588 2011-07-12
JP2017093388A JP6867866B2 (ja) 2011-06-01 2017-05-09 細菌のポリシストロン性発現系

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017093388A Division JP6867866B2 (ja) 2011-06-01 2017-05-09 細菌のポリシストロン性発現系

Publications (2)

Publication Number Publication Date
JP2021097671A JP2021097671A (ja) 2021-07-01
JP2021097671A5 true JP2021097671A5 (enExample) 2021-08-12

Family

ID=46354175

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014513212A Active JP6175428B2 (ja) 2011-06-01 2012-06-01 細菌のポリシストロン性発現系
JP2017093388A Active JP6867866B2 (ja) 2011-06-01 2017-05-09 細菌のポリシストロン性発現系
JP2021015026A Pending JP2021097671A (ja) 2011-06-01 2021-02-02 細菌のポリシストロン性発現系

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2014513212A Active JP6175428B2 (ja) 2011-06-01 2012-06-01 細菌のポリシストロン性発現系
JP2017093388A Active JP6867866B2 (ja) 2011-06-01 2017-05-09 細菌のポリシストロン性発現系

Country Status (13)

Country Link
US (3) US9920324B2 (enExample)
EP (2) EP3360967B1 (enExample)
JP (3) JP6175428B2 (enExample)
KR (1) KR102066292B1 (enExample)
CN (2) CN103562390B (enExample)
AU (2) AU2012264589B2 (enExample)
BR (1) BR112013030824A8 (enExample)
CA (2) CA2837634C (enExample)
DK (1) DK2714912T3 (enExample)
ES (1) ES2676877T3 (enExample)
HU (1) HUE039577T2 (enExample)
RU (2) RU2766157C2 (enExample)
WO (1) WO2012164083A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3360967B1 (en) 2011-06-01 2020-09-09 Intrexon Actobiotics NV Polycistronic expression system for bacteria
US9593339B1 (en) * 2013-02-14 2017-03-14 David Gordon Bermudes Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
JPWO2015022798A1 (ja) * 2013-08-13 2017-03-02 学校法人北里研究所 新規テルペノイド化合物およびその製造方法
DK3228706T3 (da) * 2014-12-03 2021-07-26 Azusapharma Sciences Inc Coekspressionsplasmid
KR102297619B1 (ko) 2014-12-23 2021-09-02 일리야 팔마 에이비 상처 치유 방법
WO2016180747A1 (en) * 2015-05-10 2016-11-17 Ventana Medical Systems, Inc. Compositions and methods for simultaneous inactivation of alkaline phosphatase and peroxidase enzymes during automated multiplex tissue staining assays
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
EP3402499B1 (en) 2016-01-14 2021-07-21 Intrexon Actobiotics NV Compositions and methods for the treatment of type 1 diabetes
CA3035151A1 (en) * 2016-09-02 2018-03-08 Intrexon Actobiotics N.V. Genetically modified bacteria stably expressing il-10 and insulin
AU2017328129B2 (en) 2016-09-13 2021-01-28 Intrexon Actobiotics N.V. Mucoadhesive microorganism
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
GB201906775D0 (en) * 2019-05-14 2019-06-26 Res & Innovation Uk Synthetic genome
EP4034144A1 (en) 2019-09-27 2022-08-03 Intrexon Actobiotics NV d/b/a Precigen Actobio Treatment of celiac disease
WO2024003873A1 (en) 2022-06-30 2024-01-04 Intrexon Actobiotics Nv D/B/A Precigen Actobio Single variable domain antibodies against tumor necrosis factor-alpha

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB227835A (en) 1924-01-15 1925-04-09 Harry Odell Improvements in feeding mechanism for embossing and other printing presses
JPS58116498A (ja) 1981-12-28 1983-07-11 Takeda Chem Ind Ltd Ｉｌ‐２をコードする新規伝令ｒｎａの製造法
EP0091539B2 (en) 1982-03-31 1996-11-27 Ajinomoto Co., Inc. Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4752585A (en) 1985-12-17 1988-06-21 Cetus Corporation Oxidation-resistant muteins
JPH01196296A (ja) * 1988-01-29 1989-08-08 Toray Ind Inc 動物細胞用発現ベクター
US4919918A (en) 1988-03-14 1990-04-24 Spectrum Consumer Products Co., Inc. Non-alcoholic mouthwash
US5972685A (en) 1988-07-21 1999-10-26 Iowa State University Research Foundation, Inc. Oral administration of coprostanol producing microorganisms to humans to decrease plasma cholesterol concentration
GB9006400D0 (en) 1990-03-22 1990-05-23 Ciba Geigy Ag Bacterial vectors
DE69232619T2 (de) 1991-02-14 2002-09-12 The General Hospital Corp., Charlestown Intestinale kleeblatt-proteine
US6221840B1 (en) 1991-02-14 2001-04-24 The General Hospital Corporation Intestinal trefoil proteins
US6277969B1 (en) 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
GB9126306D0 (en) 1991-12-11 1992-02-12 Unilever Plc Mouthwash compositions
US6221648B1 (en) 1992-02-27 2001-04-24 Microdial Technics Ltd. Heterologous gene expression in lactococcus, and the expression products therefrom
US5223285A (en) 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
EP0569604A1 (en) * 1992-04-07 1993-11-18 Societe Des Produits Nestle S.A. Integrative gene-expression in Streptococcus salivarius ssp.thermophilus
US5229109A (en) 1992-04-14 1993-07-20 Board Of Regents, The University Of Texas System Low toxicity interleukin-2 analogues for use in immunotherapy
US5700782A (en) 1993-05-28 1997-12-23 Abbott Laboratories Enteral nutritional product
WO1996032486A1 (en) 1995-04-11 1996-10-17 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for the construction of vectors for lactic acid bacteria like lactobacillus such that the bacteria can efficiently express, secrete and display proteins at the surface
US5695746A (en) 1995-07-28 1997-12-09 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Liquid dentifrice with mouthwash fresh taste
GB9521568D0 (en) 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
AU1533697A (en) 1996-01-24 1997-08-20 Warner-Lambert Company Peroxide/essential oils containing mouthwash compositions and two-part mouthwash systems
GB9611364D0 (en) 1996-05-31 1996-08-07 Smithkline Beecham Plc Composition
AU4342497A (en) 1996-09-18 1998-04-14 Erling Johansen Mouthwash comprising calcium and phosphate ions in supersaturated solution
US5869118A (en) 1996-11-13 1999-02-09 Abbott Laboratories Gellan gum to improve physical stability of liquid nutritional products
US6171611B1 (en) 1997-11-12 2001-01-09 Dante J. Picciano Iodine-containing nasal moisturizing saline and mouthwash solutions
US5897872A (en) 1997-11-12 1999-04-27 Picciano; Dante J. Iodine-containing nasal moisturizing saline solution
KR100695562B1 (ko) 1998-09-28 2007-03-15 워너-램버트 캄파니 엘엘씨 Ｈｐｍｃ 캡슐을 이용한 장 및 결장에의 전달방법
AU1071200A (en) 1998-10-19 2000-05-08 Biotech Australia Pty Limited Systems for oral delivery
CA2343840C (en) 1998-10-20 2011-03-08 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Use of a cytokine-producing lactococcus strain to treat colitis
US6929931B1 (en) 1999-06-30 2005-08-16 Nestec S.A. Expression contructs using Lactobacillus delbrueckii subsp. lactis lac repressor protein and its lac repressor binding site, microorganisms and methods thereof
EP1739178B1 (en) 1999-07-05 2010-09-08 Actogenix N.V. Delivery of trefoil peptides
AU2001238582A1 (en) * 2000-02-24 2001-09-03 Siga Pharmaceuticals, Inc Intergenic and intragenic integration sites for foreign gene expression in recombinant s. gordonii strains
US7029842B2 (en) * 2000-04-07 2006-04-18 Novozymes A/S Signal sequence trapping
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
EP1383897B1 (en) 2001-05-03 2006-06-28 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Self-containing lactococcus strain
EP1319410A1 (en) * 2001-12-11 2003-06-18 Société des Produits Nestlé S.A. Use of micro-organisms for a directed delivery of substances to specific parts of the gut
US20040076590A1 (en) 2002-07-08 2004-04-22 Wilkins Joe S. Antibacterial toothpaste and mouthwash formulations
EP1560935A2 (en) 2002-11-15 2005-08-10 VIB vzw Self-containing lactobacillus strain
MXPA05008131A (es) 2003-01-31 2005-10-05 Univ Pennsylvania Metodos para la modulacion de una respuesta inflamatoria.
EP1493816A1 (en) * 2003-07-02 2005-01-05 Friesland Brands B.V. Methods and means for regulating gene expression
WO2005007121A2 (en) 2003-07-18 2005-01-27 Massachusetts Institute Of Technology Mutant interleukin-2(il-2) polypeptides
US7842289B2 (en) * 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
MXPA06007144A (es) 2003-12-24 2007-01-31 Cerus Corp Moleculas de acido nucleico recombinante que codifican proteinas de fusion que comprenden polipeptidos de senal secretoria bacterial y de antigenos, casetes de expresion y bacterias, y metodos para usar las mismas.
US20060234205A1 (en) 2004-03-05 2006-10-19 Chiron Corporation In vitro test system for predicting patient tolerability of therapeutic agents
US7495092B2 (en) * 2005-01-14 2009-02-24 North Carolina State University Compositions comprising promoter sequences and methods of use
US7764366B2 (en) 2006-07-11 2010-07-27 Besi North America, Inc. Robotic die sorter with optical inspection system
JP2009544679A (ja) * 2006-07-25 2009-12-17 ザ ユニヴァーシティー コート オブ ザ ユニヴァーシティー オブ ダンディー 異常な細胞増殖に関連する疾患の治療におけるレチノイド及び小分子のＮｒｆ２アンタゴニストとしての使用
CA2675115C (en) 2007-01-12 2014-12-09 Actogenix N.V. Lactococcus promoters and uses thereof
US9574169B2 (en) 2009-04-30 2017-02-21 Intrexon Actobiotics Nv Cryoprotectants for freeze drying of lactic acid bacteria
EP3075745B1 (en) 2011-02-10 2018-09-05 Roche Glycart AG Mutant interleukin-2 polypeptides
BR112013023151A2 (pt) 2011-03-11 2020-09-15 Assistance Publique - Hôpitaux De Paris interleucina-2 para uso no tratamento de desordem auto-imune, !muno-relacionada ou inflamatória e método para determinar se um regime ou dose de il-2 tem de ser modificado
EP3360967B1 (en) 2011-06-01 2020-09-09 Intrexon Actobiotics NV Polycistronic expression system for bacteria
EP2753362A4 (en) 2011-09-08 2015-04-15 Univ Florida MATERIALS AND METHOD FOR MODULATING IMMUNE SYSTEM REACTIONS
EP3402499B1 (en) 2016-01-14 2021-07-21 Intrexon Actobiotics NV Compositions and methods for the treatment of type 1 diabetes

Similar Documents

Publication Publication Date Title
JP2021097671A5 (enExample)
CN112501102B (zh) 一株高效生产四氢嘧啶的大肠杆菌重组菌
JP2020506667A5 (enExample)
JP2010187673A5 (enExample)
JP2012528572A5 (enExample)
JP2018521630A5 (enExample)
CN108277231B (zh) 一种用于棒状杆菌基因组编辑的crispr系统
JP2013530689A5 (enExample)
WO2012172277A4 (en) Simian adenovirus and hybrid adenoviral vectors
NZ592082A (en) Promoters for recombinant viral expression
JP7481755B2 (ja) 組換えパルボウイルスベクターならびにその作製および使用方法
CN115551879A (zh) Drw1蛋白调控水稻株高和种子大小的应用
JP2020517270A5 (enExample)
Nishigawa et al. Evidence of intermolecular recombination between extrachromosomal DNAs in phytoplasma: a trigger for the biological diversity of phytoplasma?
JPWO2019183150A5 (enExample)
JPWO2021202568A5 (enExample)
CN115124604B (zh) 一种重组抗菌肽e-ej97、重组表达载体、工程菌及其应用
CN104388456A (zh) 一种同时表达两条sgRNA的载体的构建方法
CN103589744B (zh) 一种敲除prcR基因的自杀质粒pYTRLRRT及其构建方法
JPWO2023039378A5 (enExample)
JPWO2022196245A5 (enExample)
JP4465741B2 (ja) 二本鎖ｄｎａ断片の末端での連結
JPWO2022051020A5 (enExample)
JP3743525B2 (ja) 部位特異的変異導入方法
CN102321660A (zh) 一种dna克隆方法